NS

Nilesh Shyamdhar Shukla

Active Director Director DIN 11221967
DIN 11221967 First appointment Jul 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Nilesh Shyamdhar Shukla

Data last updated:

Nilesh Shyamdhar Shukla is a Director at Healixa Overseas Private Limited (since 2025). The company operates in Healthcare.

DIN 11221967
Primary Designation Director
Industry Healthcare
First Appointment 31 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Healixa Overseas Private Limited U46596MH2025PTC453416
Director31 Jul 20252025Active

Board colleagues of Nilesh Shyamdhar Shukla

NameDINCompanyDesignation
Rajesh Rajbahadur Yadav07986304Healixa Overseas Private LimitedDirector

Directorship timeline

Open interactive timeline →
Healixa Overseas Private Limited
Premium access

Shareholding and investment profile for Nilesh Shyamdhar Shukla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nilesh Shyamdhar Shukla

Nilesh Shyamdhar Shukla currently holds 1 directorship: Healixa Overseas Private Limited (Director, since 31 Jul 2025).

Nilesh Shyamdhar Shukla was first appointed on 31 Jul 2025 as Director at Healixa Overseas Private Limited.

The current boards of Nilesh Shyamdhar Shukla's companies include Rajesh Rajbahadur Yadav (Healixa Overseas Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available